Butterfly Needles Market is estimated to be valued at USD 2.78 Bn in 2026 and is expected to reach USD 5.04 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 2.78 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
8.90% |
2033 Value Projection: |
USD 5.04 Bn |
The global butterfly needles market includes offerings that span (5mm - 8mm, 9mm - 12mm, 13mm - 16mm, 17mm - 20mm and Others (above 20mm, pediatric lengths, etc.)), and similar needle length categories. These are applied across (21G - 23G, 24G - 26G, 27G - 30G, 31G - 33G and Others (18G - 20G, 34G - 36G etc.)), By End User (Hospitals, Blood Banks, Diagnostic Centers, Home Healthcare and Others (Physician Offices, Clinics)), and By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) and adopted by diverse end users. As organizations increasingly prioritize performance, efficiency, and cost-effectiveness, adoption across these segments continues to grow steadily.
Market Dynamics:
Increasing demand from major end-use sectors, the need for improved efficiency and reliability, and ongoing product innovation are major factors expected to drive growth of the global butterfly needles market. Broader adoption across (21G - 23G, 24G - 26G, 27G - 30G, 31G - 33G and Others (18G - 20G, 34G - 36G etc.)), and By End User (Hospitals, Blood Banks, Diagnostic Centers, Home Healthcare and Others (Physician Offices, Clinics)) is reinforcing this momentum.
For instance, market players are introducing advanced solutions designed for (21G - 23G, 24G - 26G, 27G - 30G, 31G - 33G and Others (18G - 20G, 34G - 36G etc.)) use cases. Moreover, continued technological advancement and strategic investment are expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global butterfly needles market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Alshifa Medical Syringes, Asahi Kasei Medical, Beijing PuYi Medical Technology Co, Bionic Medizintechnik, Biosigma SPA, Changzhou Zener Medtec, Demophorius Healthcare, Dialife SA, Epimed, F.B. Medical, Farmasol, HeBei ChaoRan Medical Instruments, HWTAi, Jiangsu Eyoung Medical Devices, Kawasumi, KB Medical Group, Lepu Medical Technology, Micsafe Medical, Nanchang Kindly Meditech, Nemoto, Nipro, NxStage Medical, Oscar Boscarol, PakuMed Medical Products, and Sunrise Medical Technology, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global butterfly needles market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global butterfly needles market.
Detailed Segmentation:
- Global Butterfly Needles Market, By Needle Length (Revenue, USD Bn, 2021 - 2033)
- (5mm - 8mm, 9mm - 12mm, 13mm - 16mm, 17mm - 20mm and Others (above 20mm, pediatric lengths, etc.))
- Global Butterfly Needles Market, By Gauge Size (Revenue, USD Bn, 2021 - 2033)
- (21G - 23G, 24G - 26G, 27G - 30G, 31G - 33G and Others (18G - 20G, 34G - 36G etc.))
- By End User (Hospitals, Blood Banks, Diagnostic Centers, Home Healthcare and Others (Physician Offices, Clinics))
- By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Alshifa Medical Syringes*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Asahi Kasei Medical
- Beijing PuYi Medical Technology Co
- Bionic Medizintechnik
- Biosigma SPA
- Changzhou Zener Medtec
- Demophorius Healthcare
- Dialife SA
- Epimed
- F.B. Medical
- Farmasol
- HeBei ChaoRan Medical Instruments
- HWTAi
- Jiangsu Eyoung Medical Devices
- Kawasumi
- KB Medical Group
- Lepu Medical Technology
- Micsafe Medical
- Nanchang Kindly Meditech
- Nemoto
- Nipro
- NxStage Medical
- Oscar Boscarol
- PakuMed Medical Products
- Sunrise Medical Technology
"*" marked represents similar segmentation in other categories in the respective section.